Havrix: 1 mL IM followed by a 1 mL booster dose 6 to 12 months following primary immunization. Primary immunization is recommended at least 2 weeks before expected exposure to hepatitis A virus. Immune globulin may be administered with the vaccine (at a different injection site) to patients re...
Important Safety Information for HAVRIX Severe allergic reaction (eg, anaphylaxis) after a previous dose of any hepatitis A-containing vaccine, or to any component of HAVRIX, including neomycin, is a contraindication to administration of HAVRIX The tip cap of the prefilled syringe may or may not...
They receive inactivated aluminum-adsorbed hepatitis A vaccine instead of a third dose of Aimmugen®. This study was undertaken to determine whether the booster vaccination with an aluminum-adsorbed hepatitis A vaccine is effective following two doses of Aimmugen®.MethodsSubjects were healthy ...
The vaccination with Havrix could be allowed to be used instead of a third dose of Aimmugen. (UMIN000009351). 展开 关键词: Aluminum-adsorbed hepatitis A vaccine Aluminum-free hepatitis A vaccine Immunogenicity Interchangeability Safety DOI: 10.1016/j.vaccine.2017.10.002 ...
Vaccine 2015;33: 5723-7.Theeten H, Van Herck K, Van Der Meeren O, Crasta P, Van Damme P, Hens N. Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions. Vaccine. 2015...
Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial Dose-sparing strategies and new production technologies will be necessary to produce adequate supplies of vaccines for pandemic influenza. One approach is ... W ...
Delaying the third dose of Japanese aluminum-free hepatitis A vaccine Aimmugen elicits effective immune responses against hepatitis A in adults. 2023 Elsevier LtdInactivated aluminum-adsorbed hepatitis A vaccines such as Havrix, Vaqta, and Avaxim are commonly used worldwide. These vaccines are typic....
2 months after the second dose, 3 months after the third dose, and 19 months after the first dose. Three infants, not included in the data presented above, had preexisting maternal antibodies; one never responded to the vaccine and the other two did not respond until maternal antibody ...
The mean antibody titres 4 weeks after the second vaccine dose were 2978, 4346 and 1589 mIU/ml in subjects who were randomised to Vaqta 50 U/dose, Vaqta 100 U/dose and Havrix 1440 U/dose, respectively. The 2 vaccines had similar immunogenicity but local tolerance was better with Vaqta....